NASDAQ-listed iKang Healthcare Group has adopted a poison pill plan to thwart a higher and competing take-private bid from rival Meinian Onehealth Healthcare (Group) Co., Ltd., according to an announcement.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?